[Treatment of patients with initial manifestations of cerebrovascular insufficiency in atherosclerosis].
Kanareĭkin
K F
KF
Manvelov
L S
LS
Shvedkov
V V
VV
D000925:Anticoagulants / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications*; D001921:Brain / Q000098:blood supply; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002560:Cerebrovascular Circulation; D003131:Combined Modality Therapy; D004032:Diet; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D011613:Psychotherapy; D012028:Reflexotherapy; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D000975:Antioxidants; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D014149:Tranquilizing Agents; D014665:Vasodilator Agents
Lechenie bolńykh nachalńymi proiavleniiami nedostatochnosti krovosnabzheniia mozga pri ateroskleroze.